Telomerase expression in uveal melanoma

British Journal of Ophthalmology

Volumn 84, Issue 2, 2000, Pages 217-223

  Heine, Bernhard ^a,c   Coupland, Sarah E ^a   Kneiff, Sören ^a   Demel, Gudrun ^a   Bornfeld, Norbert ^b   Hummel, Michael ^a   Stein, Harald ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UKBF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TELOMERASE;

ADULT; AGED; ARTICLE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; LENS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR LOCALIZATION; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TELOMERASE; UVEAL NEOPLASMS;

EID: 0034059707     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.2.217     Document Type: Article

References (60)

1. Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-6.
2. Watson JD. Origin of concatemeric T7 DNA. Nat New Biol 1972;239:197-201.
3. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973;41:181-90.
4. Lindsey GG, Orgeig S, Thompson P, et al. Extended C-terminal tail of wheat histone H2A interacts with DNA of the "linker" region. J Mol Biol 1991;218:805-13.
5. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-60.
6. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-13.
7. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells [see comments]. Science 1998;279:349-52.
8. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer [see comments]. Science 1994;266:2011-5.
9. Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-6.
10. Heine B, Hummel M, Demel G, et al. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization. J Pathol 1998;185:139-44.
11. Heine B, Hummel M, Muller M, et al. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. J Pathol 1998;184:71-6.
12. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
13. Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-22.
14. Langford LA, Piatyszek MA, Xu R, et al. Telomerase activity in human brain tumours. Lancet 1995;346:1267-8
15. Tahara H, Kuniyasu H, Yokozaki H, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995;1:1245-51.
16. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995;92:9082-6.
17. Chiu CP, Dragowska W, Kim NW, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996;14:239-48.
18. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-5.
19. Hummel M, Heine B, Demel G, Stein H. [Telomerase as a tumor marker?] Verh Dtsch Ges Pathol 1997;81:312-7.
20. Taylor RS, Ramirez RD, Ogoshi M, et al. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996;106:759-65.
21. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
22. Avilion AA, Piatyszek MA, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996;56:645-50.
23. Bodnar AG, Kim NW, Effros RB, et al. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996;228:58-64
24. Yashima K, Piatyszek MA, Saboorian HM, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997;50:110-7.
25. Yashima K, Litzky LA, Kaiser L, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997;57: 2373-7.
26. Yashima K, Maitra A, Rogers BB, et al. Expression of the RNA component of telomerase during human development and differentiation. Cell Growth Differ 1998;9:805-13.
27. Soder AI, Going JJ, Kaye SB, et al. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogens 1998;16:979-83.
28. Jensen OA. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol Copenh 1982;60:161-82.
29. Janssen K, Kuntze J, Busse H, et al. p53 oncoprotein overexpression in choroidal melanoma. Mod Pathol 1996;9:267-72.
30. Tobal K, Warren W, Cooper CS, et al. Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 1992;66:900-4.
31. Ohta M, Berd D, Shimizu M, et al. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. Int J Cancer 1996;65:762-7.
32. Coupland SE, Bechrakis N, Schuler A, et al. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma. Br J Ophthalmol 1998;82:961-70.
33. Horsman DE, White VA. Cytogenetic analysis of uveal melanoma. Consistent occurrence of monosomy 3 and trisomy 8q. Cancer 1993;71:811-9.
34. Prescher G, Bornfeld N, Becher R. Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst 1990;82:1765-9.
35. Sisley K, Cottam DW, Rennie IG, et al. Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer 1992;5: 197-200.
36. McLean IW, Foster WD, Zimmerman LE, et al. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983;96:502-9.
37. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994;173:371-9.
38. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-29.
39. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133: 1710-5.
40. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
41. Key G, Becker MH, Baron B, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;68:629-36.
42. Kivela T. Immunohistochemical staining followed by bleaching of melanin: a practical method for ophthalmic pathology [letter; comment]. Br J Biomed Sci 1995;52:325-6.
43. Aldous WK, Grabill NR. A fluorescent method for detection of telomerase activity. Diagn Mol Pathol 1997;6: 102-10.
44. Foss HD, Herbst H, Oelmann E, et al. Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol 1993;84:627-35.
45. Ogoshi M, Le T, Shay JW, et al. In situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J Invest Dermatol 1998;110:818-23.
46. Sallinen P, Miettinen H, Sallinen SL, et al. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 1997;150:1159-64.
47. Rushing EJ, Yashima K, Brown DF, et al. Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas. J Neuropathol Exp Neurol 1997;56:1142-6.
48. Hiraga S, Ohnishi T, Izumoto S, et al. Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 1998;58:2117-25.
49. Kleinschmidt-DeMasters BK, Hashizumi TL, Sze CI, et al. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling. J Clin Pathol 1998;51:284-93.
50. Okayasu I, Osakabe T, Fujiwara M, et al. Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension. Jpn J Cancer Res 1997;88:965-70.
51. Albanell J, Lonardo F, Rusch V, et al. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J Natl Cancer Inst 1997;89:1609-15.
52. Okayasu I, Mitomi H, Yamashita K, et al. Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas. J Cancer Res Clin Oncol 1998;124:444-9.
53. Ohmura H, Tahara H, Suzuki M, et al. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995;86:899-904.
54. Horikawa I, Oshimura M, Barrett JC. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 1998;22:65-72.
55. Blasi MA, Roccella F, Balestrazzi E, et al. 3p13 region: a possible location of a tumor suppressor gene involved in uveal melanoma. Cancer Genet Cytogenet 1999;108:81-3.
56. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347: 1222-5.
57. Cotlier E. The mitotic cycle of the lens epithelium:effect of age and galactose. Arch Ophthalmol 1962;68:801.
58. Yamaguchi Y, Nozawa K, Savoysky E, et al. Change in telomerase activity of rat organs during growth and aging. Exp Cell Res 1998;242:120-7.
59. Allsopp RC, Chang E, Kashefi-Aazam M, et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995;220:194-200.
60. Maitra A, Yashima K, Rathi A, et al. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 1999; 85:741-9.